The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to DNA-Damaged Induced Apoptosis through Inhibition of p21 Translation
Open Access
- 25 March 2005
- journal article
- Published by Elsevier BV in Cell
- Vol. 120 (6), 747-759
- https://doi.org/10.1016/j.cell.2004.12.040
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Mammalian target of rapamycin (mTOR) Inhibitors.Current Oncology Reports, 2004
- Antitumor Efficacy of Intermittent Treatment Schedules with the Rapamycin Derivative RAD001 Correlates with Prolonged Inactivation of Ribosomal Protein S6 Kinase 1 in Peripheral Blood Mononuclear CellsCancer Research, 2004
- The role of p53 in chemosensitivity and radiosensitivityOncogene, 2003
- Proteasome-Mediated Degradation of p21 via N-Terminal UbiquitinylationCell, 2003
- Rapamycin-induced G1 arrest in cycling B-CLL cells is associated with reduced expression of cyclin D3, cyclin E, cyclin A, and survivinBlood, 2003
- Mammalian TOR: A Homeostatic ATP SensorScience, 2001
- Pathways governing G1/S transition and their response to DNA damageFEBS Letters, 2001
- The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblastsThe EMBO Journal, 1999
- Cells lacking CIP1/WAF1 genes exhibit preferential sensitivity to cisplatin and nitrogen mustardOncogene, 1997
- WAF1, a potential mediator of p53 tumor suppressionCell, 1993